Testosterone Replacement Therapy: Long-Term Safety and Efficacy
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Recent position statements and guidelines have raised the distinction between a true and false, age-related hypogonadism (HG) or late-onset hypogonadism (LOH). The former is the consequence of congenital or acquired "organic" damage of the brain centers or of the testis. The latter is mainly secondary to age-related comorbidities and does not require testosterone (T) therapy (TTh). In addition, concerns related to cardiovascular (CV) safety have further increased the scepticism related to TTh. In this paper, we reviewed the available evidence supporting the efficacy of TTh in non-organic HG and its long term safety. A large amount of evidence has documented that sexual symptoms are the most specific correlates of T deficiency. TTh is able to improve all aspects of sexual function independent of the pathogenetic origin of the disease supporting the scientific demonstration that LOH does exist according to an "ex-juvantibus" criterion. Although the presence of metabolic derangements could mitigate the efficacy of TTh on erectile dysfunction, the positive effect of TTh on body composition and insulin sensitivity might counterbalance the lower efficacy. CV safety concerns related to TTh are essentially based on a limited number of observational and randomized controlled trials which present important methodological flaws. When HG is properly diagnosed and TTh correctly performed no CV and prostate risk have been documented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544 · cited 14×
“, decreased frequency of sexual thoughts, decreased morning erections, and erectile dysfunction (ED)—are the most sensitive and specific symptoms in identifying patients with low T [12].”
BackgroundResultInfluentialVigen, R. (2013) · JAMA · doi:10.1001/jama.2013.280386 · Cited by 1,003 · cited 3×
“In particular, besides the two aforementioned observational studies, several other reports were published either previously or thereafter [34,35,38-48].”
BackgroundResultIncreased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men
Finkle, W. D., Greenland, S., Ridgeway, G. K., Adams, J. L., Frasco, M. A., Cook, M. B., Fraumeni, J. F., & Hoover, R. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085805 · Cited by 735 · cited 3×
“In particular, besides the two aforementioned observational studies, several other reports were published either previously or thereafter [34,35,38-48].”
BackgroundResultCalof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728 · cited 2×
“Comparisons of the available meta-analyses evaluating the relationship between testosterone therapy and prostate safety Variable Calof et al (2005) [49] FernándezBalsells et al (2010) [51] Cui and Zhang (2013) [64] Cui et al (2014) [65] Guo et al (2016) [67] Kang et al (2015) [66] Boyle et al (2016) [62] No. of trials…”
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0955 · Cited by 414
Self-citationCorona, G., Maseroli, E., Rastrelli, G., Isidori, A. M., Sforza, A., Mannucci, E., & Maggi, M. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.950653 · Cited by 297 · cited 3×
“Eight systematic meta-analyses on the association between TTh and CV risk have been published so far (Table 4) [49-56].”
BackgroundSelf-citationTestosterone supplementation and sexual function: A meta-analysis study
Corona, G., Isidori, A. M., Buvat, J., Aversa, A., Rastrelli, G., Hackett, G., Rochira, V., Sforza, A., Lenzi, A., Mannucci, E., et al. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12536 · Cited by 263 · cited 14×
“In contrast with the last report, we previously documented, using a meta-analytic method, that TTh is superior, when compared to placebo, in improving all aspects of sexual function [26].”
BackgroundMethodResultInfluentialSelf-citationCorona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0262 · Cited by 217 · cited 1×
“Although the presence of metabolic derangements could limit the efficacy of TTh on ED, the positive effect of TTh on body composition and insulin sensitivity [30-32] might counterbalance the lower efficacy.”
BackgroundSelf-citationCorona, G., Giagulli, V. A., Maseroli, E., Vignozzi, L., Aversa, A., Zitzmann, M., Saad, F., Mannucci, E., & Maggi, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0480-2 · Cited by 185 · cited 1×
“Although the presence of metabolic derangements could limit the efficacy of TTh on ED, the positive effect of TTh on body composition and insulin sensitivity [30-32] might counterbalance the lower efficacy.”
BackgroundSelf-citationObesity and late-onset hypogonadism
Corona, G., Vignozzi, L., Sforza, A., Mannucci, E., & Maggi, M. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.031 · Cited by 154
Self-citationTreatment of Men for “Low Testosterone”: A Systematic Review
Huo, S., Scialli, A. R., McGarvey, S., Hill, E., Tügertimur, B., Hogenmiller, A., Hirsch, A. I., & Fugh-Berman, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162480 · Cited by 97 · cited 3×
“In addition, they included both eugonadal and hypogonadal subjects in the analysis [25].”
BackgroundMethodInfluentialEmerging medication for the treatment of male hypogonadism
Corona, G., Rastrelli, G., Vignozzi, L., & Maggi, M. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.683411 · Cited by 93 · cited 1×
“In all the other cases, testosterone therapy (TTh) is the most convenient choice [15].”
BackgroundSelf-citationAlbert, S. G., & Morley, J. E. (2016) · Clinical Endocrinology · doi:10.1111/cen.13084 · Cited by 91 · cited 3×
“Eight systematic meta-analyses on the association between TTh and CV risk have been published so far (Table 4) [49-56].”
BackgroundPerspective: Regulatory Agencies' Changes to Testosterone Product Labeling
Corona, G., & Maggi, M. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12951 · Cited by 41
Self-citationTestosterone treatment in older men
(2016) · New England Journal of Medicine · doi:10.1056/nejmc1603665 · Cited by 25
Cited by
Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies
Corona, G., Rastrelli, G., Di Pasquale, G., Sforza, A., Mannucci, E., & Maggi, M. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.04.641 · Cited by 138
Self-citationTestosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
Song, S.-H., Sung, S., Her, Y. S., Oh, M., Shin, D. H., Lee, J., Baek, J., Lee, W. S., & Kim, D. S. (2019) · Clinical and Experimental Reproductive Medicine · doi:10.5653/cerm.2019.00290 · Cited by 14
“The benefits of TRT include increased growth of body hair, energy, muscle mass and stamina, overall confidence, and motivation [1].”
Background
Metadata
- Authors
- Corona, G., Sforza, A., & Maggi, M.
- Venue
- The World Journal of Men's Health
- Publisher
- XMLink
- Published
- 2017
- Volume
- 35
- Issue
- 2
- Pages
- 65
- ISSN
- 2287-4208 (ISSN-L)
- 2287-4690
- OpenAlex
- W2624926308
- Cited by
- 60
- References
- 16
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.